Skip to main content
. 2019 Apr 12;9:262. doi: 10.3389/fonc.2019.00262

Figure 6.

Figure 6

DEPDC1 activated PI3K/AKT/mTOR signaling pathway. (A) GSEA showed that DEPDC1 level was positively associated with PI3K_AKT_ACTIVATION gene set in breast cancer. Samples from TCGA_BRCA were divided into low- and high- DEPDC1 expression groups. (B) Gene signatures of PI3K/AKT/mTOR signaling activation were enriched in patients with DEPDC1-higher expression group. (C) The phosphorylation of PI3K p85 (Tyr458), AKT (Ser473) and mTOR (Ser2448) were activated when DEPDC1 were overexpressed in MCF-7. NES, normalized enrichment score; FDR, false discovery rate; FDR < 0.25 is a widely accepted cutoff for the identification of biologically significant gene sets.